Xcout IntelAloft Biotechnologies, Inc.
Aloft Biotechnologies is a biotechnology company that develops microgravity biomanufacturing technology for space and terrestrial applications. The company provides cell processing, microbial culture, and fluid management systems designed for medical innovation and drug manufacturing in Low Earth Orbit.
Subscribe to see Aloft Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aloft Biotechnologies, Inc. at a glance
Aloft Biotechnologies, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $130,000 in February 2025. Xcout tracks 3 named people at Aloft Biotechnologies, Inc., including Shannon Fedenko (CEO).
Aloft Biotechnologies, Inc. leadership
- Shannon FedenkoCEO
- Isaac Finger BakerPresident
- Isaac Finger BakerExecutive Officer
Aloft Biotechnologies, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $130,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Aloft Biotechnologies, Inc. competitors
A few of Aloft Biotechnologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
BioOrbit is a UK-based biotech startup headquartered in London. The company builds infrastructure for scalable pharmaceutical manufacturing in space, using protein crystallization to turn hospital treatments into self-injectable home medicines.
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
Alvotech specializes in the development and manufacturing of biosimilars to expand access to affordable biologic medicines for patients worldwide. The company utilizes a vertically integrated approach spanning from cell line development to fill and finish manufacturing.
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Get Aloft Biotechnologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Aloft Biotechnologies, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access